Genetic Variation in the MBL2 Gene Is Associated with Chlamydia trachomatis Infection and Host Humoral Response to Chlamydia trachomatis Infection

Int J Mol Sci. 2022 Aug 18;23(16):9292. doi: 10.3390/ijms23169292.

Abstract

This study aims to assess the potential association of MBL2 gene single nucleotide polymorphisms (SNPs) to Chlamydia trachomatis infection. We analysed a selected sample of 492 DNA and serum specimens from Dutch Caucasian women. Women were categorized into four groups of infection status based on the results of DNA and antibody tests for C. trachomatis: Ct-DNA+/IgG+, Ct-DNA+/IgG−, Ct-DNA−/IgG+, and Ct-DNA−/IgG−. We compared six MBL2 SNPs (−619G > C (H/L), −290G > C (Y/X), −66C > T (P/Q), +154C > T (A/D), +161A > G (A/B), and +170A > G (A/C)) and their respective haplotypes in relation to these different subgroups. The −619C (L) allele was less present within the Ct-DNA−/IgG+ group compared with the Ct-DNA−/IgG− group (OR = 0.49; 95% CI: 0.28−0.83), while the +170G (C) allele was observed more in the Ct-DNA+/IgG+ group as compared with the Ct-DNA−/IgG− group (OR = 2.4; 95% CI: 1.1−5.4). The HYA/HYA haplotype was more often present in the Ct-DNA−/IgG− group compared with the Ct-DNA+/IgG+ group (OR = 0.37; 95% CI: 0.16−0.87). The +170G (C) allele was associated with increased IgG production (p = 0.048) in C. trachomatis PCR-positive women. This study shows associations for MBL in immune reactions to C. trachomatis. We showed clear associations between MBL2 genotypes, haplotypes, and individuals’ stages of C. trachomatis DNA and IgG positivity.

Keywords: Chlamydia trachomatis; IgG; MBL2 polymorphisms.

MeSH terms

  • Antibodies, Bacterial
  • Chlamydia Infections* / genetics
  • Chlamydia Infections* / immunology
  • Chlamydia trachomatis
  • Female
  • Haplotypes
  • Humans
  • Immunity, Humoral*
  • Immunoglobulin G
  • Mannose-Binding Lectin* / genetics
  • Netherlands
  • Polymorphism, Single Nucleotide

Substances

  • Antibodies, Bacterial
  • Immunoglobulin G
  • MBL2 protein, human
  • Mannose-Binding Lectin

Grants and funding

This work was partially funded by NGI Life Sciences Pre-Seed grant reg.nr. 93611006, a EuroTransBio grant, reference number 110012 ETB. The presented work matched the work performed by the EpiGenChlamydia Consortium (Coordination Action EU-FP6, contract no. LSHG-CT-2007-037637).